Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04846725
Other study ID # IRBN372021/CHUSTE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2019
Est. completion date August 1, 2020

Study information

Verified date April 2021
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The InferiorVena Cava (IVC) with filters has been recommended when there is a contraindication or a failure of anticoagulation. Due to the side effects related to the filters, it is recommended to remove them as soon as possible. It's a retrospective study in a French hospital to evaluate the retrieval rate and predictors of filter removal. All the data of consecutive patients who had a retrievable InferiorVena Cava Filter (IVCF) inserted in the investigator center between April 2012 and November 2019 are included.


Recruitment information / eligibility

Status Completed
Enrollment 356
Est. completion date August 1, 2020
Est. primary completion date August 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients who had a cave filter placement at Saint-Etienne Hospital between april 2012 and november 2019. Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Data collection
Collect in medical records : Filter's retrieval rate Complications of vena cava filters Predictive factors of attempted inferior vena cava filters retrieval: age, the distance between the patient's home and the hospital, the indication or not given by the therapeutic medicine department, patients referred by external structures, patients whose filter was installed during the medical on-call period, the absence of a written request for filter placement, the presence of active neoplasia at the time of filter placement, a peri-surgical context.

Locations

Country Name City State
France Chu Saint-Etienne Saint-Étienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Filter's retrieval rate (%) Collect in medical records. Month: 2
Secondary Predictive factors of attempted inferior vena cava filters retrieval Collect in medical records. Month: 2
Secondary Adverse event of vena cava filters Collect in medical records. Month: 2
See also
  Status Clinical Trial Phase
Completed NCT04414332 - Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
Recruiting NCT03206372 - Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Not yet recruiting NCT02188056 - Observational Prospectif Monocentric Registry of Patients Suffering From VIE N/A
Completed NCT01729559 - Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin Phase 4
Completed NCT01466426 - The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) N/A
Recruiting NCT05150314 - Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
Active, not recruiting NCT05396157 - Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Active, not recruiting NCT00691470 - Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation Phase 2/Phase 3
Completed NCT04824118 - Clotting Parameters After Medical Abortion
Recruiting NCT03887806 - Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study
Not yet recruiting NCT06232551 - Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism N/A
Recruiting NCT05993533 - Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy
Not yet recruiting NCT05515549 - Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
Recruiting NCT04211181 - CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism N/A
Completed NCT04818151 - Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
Recruiting NCT05089227 - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study Phase 2
Completed NCT03894878 - Association Between Genetic Variant Scores and Warfarin Effect
Completed NCT00556426 - Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. N/A
Not yet recruiting NCT04158973 - CHIPs-VTE Study in Hospitalized Patients With Lung Cancer N/A